Position in AZN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$5,098,132,659
New position
Shares Held
25,849,978
first reported quarter
Ownership
1.67%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 97.1025778049018.ToString("F0")%
Shared 0.ToString("F0")%
None 2.897422195098193.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $25,087,571,930 across 12 Drug Manufacturers - General names. AZN ranks #1 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
25,849,978 | $5,098,132,659 | |
| 2 | LLY |
ELI LILLY & Co
|
5,379,364 | $4,947,777,626 | |
| 3 | JNJ |
Johnson & Johnson
|
19,347,862 | $4,729,391,386 | |
| 4 | ABBV |
AbbVie Inc.
|
12,159,427 | $2,644,553,777 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,538,545 | $2,350,291,577 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,464,889 | $1,458,491,578 | |
| 7 | AMGN |
Amgen Inc
|
3,870,863 | $1,361,963,146 | |
| 8 | PFE |
Pfizer Inc
|
43,505,563 | $1,221,636,207 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,098,132,659 | 25,849,978 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||